Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2007) | Total Docs. (3years) | Total Refs. (2007) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2007) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.083 Q1 | 99 | 17 | 54 | 3595 | 195 | 50 | 2.86 | 211.47 |  |
| 2 | Critical Reviews in Toxicology | journal | 1.915 Q1 | 129 | 32 | 78 | 5087 | 466 | 72 | 5.55 | 158.97 | |
| 3 | Natural Product Reports | journal | 2.741 Q1 | 211 | 75 | 138 | 11288 | 931 | 133 | 6.61 | 150.51 | |
| 4 | Expert Opinion on Emerging Drugs | journal | 0.950 Q2 | 54 | 45 | 124 | 4719 | 377 | 124 | 3.05 | 104.87 | |
| 5 | Expert Opinion on Therapeutic Targets | journal | 1.433 Q1 | 106 | 134 | 227 | 13332 | 756 | 212 | 3.39 | 99.49 | |
| 6 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.743 Q2 | 100 | 67 | 120 | 6384 | 333 | 118 | 2.78 | 95.28 | |
| 7 | Advances in Antiviral Drug Design | book series | 12 | 7 | 0 | 624 | 0 | 0 | 0.00 | 89.14 | | |
| 8 | Expert Opinion on Biological Therapy | journal | 1.092 Q1 | 102 | 165 | 428 | 13835 | 1378 | 425 | 3.12 | 83.85 | |
| 9 | Expert Opinion on Drug Delivery | journal | 1.077 Q1 | 133 | 55 | 162 | 4415 | 519 | 155 | 2.99 | 80.27 | |
| 10 | Expert Opinion on Drug Discovery | journal | 0.289 Q3 | 84 | 132 | 65 | 10317 | 63 | 65 | 0.97 | 78.16 | |
| 11 | Expert Opinion on Pharmacotherapy | journal | 0.577 Q2 | 93 | 274 | 698 | 20007 | 1543 | 685 | 2.23 | 73.02 | |
| 12 | Expert Review of Vaccines | journal | 0.801 Q2 | 105 | 97 | 263 | 6944 | 575 | 241 | 2.25 | 71.59 | |
| 13 | Expert Opinion on Investigational Drugs | journal | 1.190 Q1 | 117 | 170 | 411 | 12057 | 1514 | 390 | 3.87 | 70.92 | |
| 14 | BioDrugs | journal | 0.787 Q2 | 79 | 46 | 112 | 3178 | 323 | 110 | 2.87 | 69.09 | |
| 15 | Toxin Reviews | journal | 0.239 Q3 | 54 | 16 | 76 | 1078 | 60 | 71 | 0.64 | 67.38 | |
| 16 | Chinese Medicine | journal | 0.145 Q4 | 56 | 13 | 4 | 867 | 2 | 3 | 0.50 | 66.69 | |
| 17 | Clinical Pharmacokinetics | journal | 1.429 Q1 | 184 | 68 | 241 | 4519 | 1307 | 232 | 4.92 | 66.46 | |
| 18 | Current Opinion in Molecular Therapeutics | journal | 0.985 Q1 | 67 | 72 | 238 | 4448 | 607 | 213 | 2.54 | 61.78 | |
| 19 | Current Opinion in Investigational Drugs | journal | 1.033 Q1 | 83 | 113 | 438 | 6943 | 1272 | 406 | 3.04 | 61.44 | |
| 20 | Neuropsychopharmacology | journal | 3.143 Q1 | 249 | 247 | 773 | 15129 | 5007 | 741 | 6.00 | 61.25 | |
| 21 | Pharmacogenomics Journal | journal | 1.305 Q1 | 95 | 43 | 157 | 2569 | 749 | 146 | 5.40 | 59.74 | |
| 22 | Trends in Pharmacological Sciences | journal | 4.509 Q1 | 244 | 91 | 327 | 5036 | 3137 | 302 | 9.20 | 55.34 | |
| 23 | Expert Opinion on Therapeutic Patents | journal | 0.714 Q2 | 88 | 113 | 354 | 6110 | 508 | 343 | 1.43 | 54.07 | |
| 24 | Nanotoxicology | journal | 107 | 26 | 0 | 1367 | 0 | 0 | 0.00 | 52.58 | | |
| 25 | ChemMedChem | journal | 0.638 Q1 | 119 | 174 | 412 | 9148 | 825 | 410 | 2.15 | 52.57 | |
| 26 | Molecular Diagnosis and Therapy | journal | 0.396 Q3 | 68 | 42 | 172 | 2187 | 412 | 169 | 2.21 | 52.07 | |
| 27 | Current Opinion in Drug Discovery and Development | journal | 1.460 Q1 | 85 | 74 | 218 | 3851 | 892 | 202 | 3.85 | 52.04 | |
| 28 | Particle and Fibre Toxicology | journal | 1.812 Q1 | 119 | 11 | 30 | 555 | 231 | 29 | 8.11 | 50.45 | |
| 29 | Drug Discovery Today | journal | 1.362 Q1 | 215 | 148 | 861 | 7463 | 2772 | 715 | 4.35 | 50.43 | |
| 30 | Neuropharmacology | journal | 1.935 Q1 | 191 | 275 | 740 | 13822 | 3089 | 737 | 3.45 | 50.26 | |
| 31 | Drug Discovery Today: Disease Mechanisms | journal | 0.257 Q3 | 28 | 42 | 220 | 2084 | 110 | 203 | 0.42 | 49.62 | |
| 32 | Pharmacogenomics | journal | 0.973 Q2 | 100 | 171 | 302 | 8444 | 1021 | 273 | 3.31 | 49.38 | |
| 33 | Tetrahedron | journal | 1.648 Q1 | 236 | 1342 | 3739 | 65944 | 11331 | 3712 | 2.97 | 49.14 | |
| 34 | Mutagenesis | journal | 0.866 Q2 | 102 | 56 | 182 | 2732 | 489 | 177 | 2.70 | 48.79 | |
| 35 | Toxicology and Industrial Health | journal | 0.282 Q3 | 69 | 55 | 96 | 2542 | 111 | 96 | 1.09 | 46.22 | |
| 36 | Drug Safety | journal | 1.235 Q1 | 140 | 108 | 273 | 4980 | 1105 | 248 | 3.80 | 46.11 | |
| 37 | International Journal of Neuropsychopharmacology | journal | 1.818 Q1 | 125 | 90 | 238 | 4110 | 910 | 201 | 3.49 | 45.67 | |
| 38 | BMC Chemical Biology | journal | 0.740 Q2 | 21 | 2 | 8 | 91 | 17 | 8 | 1.83 | 45.50 | |
| 39 | Journal of Psychopharmacology | journal | 1.415 Q1 | 135 | 108 | 345 | 4900 | 1178 | 303 | 3.34 | 45.37 | |
| 40 | Nature Reviews Drug Discovery | journal | 7.774 Q1 | 391 | 158 | 818 | 7071 | 5391 | 294 | 7.07 | 44.75 | |
| 41 | PharmacoEconomics | journal | 1.129 Q1 | 118 | 84 | 368 | 3733 | 994 | 318 | 2.45 | 44.44 | |
| 42 | Environmental Pollution | journal | 1.843 Q1 | 301 | 465 | 1041 | 20498 | 3807 | 1030 | 3.38 | 44.08 | |
| 43 | Toxicological Sciences | journal | 1.459 Q1 | 207 | 317 | 950 | 13951 | 4118 | 923 | 4.10 | 44.01 | |
| 44 | Drugs in R and D | journal | 0.381 Q3 | 54 | 41 | 152 | 1804 | 210 | 152 | 1.65 | 44.00 | |
| 45 | Issues in Toxicology | book series | 18 | 26 | 0 | 1135 | 0 | 0 | 0.00 | 43.65 | | |
| 46 | Antiviral Chemistry and Chemotherapy | journal | 0.711 Q2 | 59 | 32 | 99 | 1372 | 200 | 97 | 1.76 | 42.88 | |
| 47 | Drug Discovery Today: Therapeutic Strategies | journal | 0.366 Q3 | 31 | 42 | 215 | 1785 | 177 | 204 | 0.67 | 42.50 | |
| 48 | Antiviral Therapy | journal | 1.704 Q1 | 93 | 149 | 371 | 6331 | 1570 | 360 | 4.02 | 42.49 | |
| 49 | Journal of Drug Targeting | journal | 0.957 Q1 | 107 | 74 | 210 | 3144 | 509 | 198 | 2.20 | 42.49 | |
| 50 | Toxicon | journal | 0.828 Q2 | 144 | 235 | 680 | 9736 | 1820 | 665 | 2.49 | 41.43 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data